Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Which breathing device helps lung surgery patients recover faster?

NCT ID NCT07737093

Disease control Sponsor: Riphah International University Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now This study
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jul 30, 2026 · Last updated Jul 31, 2026 · Updated 1 time

Summary

After a lobectomy (removal of a lung lobe), patients often struggle with mucus buildup, shortness of breath, and reduced lung function. This trial compares two handheld devices—Acapella and Flutter—that use vibration and pressure to help clear airways. About 28 adults aged 35 to 54 who are stable after surgery will use one of the devices twice daily for a week. Researchers will measure changes in breathlessness, oxygen levels, and lung function to see which device works better.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
Acapella device or Flutter device, both oscillating positive expiratory pressure (OPEP) devices used to clear mucus from the airways
What this could lead to
If one device proves better, it could become the preferred tool to help lung surgery patients recover faster and breathe easier.
What could go wrong
This is a small, early-stage trial with only 28 participants, so results may not apply to all patients. Individual responses to the devices can vary.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 28 people

The number the study aims to enrol. It can still change while the study runs.

Started

Jun 2026

Expected to finish

Dec 2026

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

35 to 54 years

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Patients aged 35 to 54 years * Both male and female patients * Patients who have undergone lobectomy surgery * Hemodynamically stable patients * Patients with adequate respiratory function (able to maintain oxygenation) * Patients 48 hours post-surgery * Patients who provide written informed consent to participate in the study Exclusion Criteria: * Hemodynamically unstable patients * Patients within less than 48 hours post-surgery * Presence of pneumothorax or air leak complications * Patients with recent major trauma or additional surgery * Patients with unstable cardiac conditions * Patients with massive hemoptysis * Patients unable to cooperate or perform breathing exercises with devices * Any contraindication to airway clearance techniques as judged by the clinician

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Lobotomy syndrome are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Lobotomy syndrome

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    1 site. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • Riphah International University

    RECRUITING

    Lahore, Punjab Province, 55000, Pakistan